LLY
795.48
+0.43%↑
JNJ
152.14
-0.14%↓
ABBV
186.94
+0.72%↑
NVO
67.74
+0.61%↑
UNH
302.46
+0.12%↑
LLY
795.48
+0.43%↑
JNJ
152.14
-0.14%↓
ABBV
186.94
+0.72%↑
NVO
67.74
+0.61%↑
UNH
302.46
+0.12%↑
LLY
795.48
+0.43%↑
JNJ
152.14
-0.14%↓
ABBV
186.94
+0.72%↑
NVO
67.74
+0.61%↑
UNH
302.46
+0.12%↑
LLY
795.48
+0.43%↑
JNJ
152.14
-0.14%↓
ABBV
186.94
+0.72%↑
NVO
67.74
+0.61%↑
UNH
302.46
+0.12%↑
LLY
795.48
+0.43%↑
JNJ
152.14
-0.14%↓
ABBV
186.94
+0.72%↑
NVO
67.74
+0.61%↑
UNH
302.46
+0.12%↑
24h
Current
Min
1.77
Max
1.86
Recommendations | Buy |
---|---|
12 Months Forecast | +455.56% upside |
Next Earnings | 11 Aug 2025 |
---|
Past performance is not a reliable indicator of future results.
10 Mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Read
10 Mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Read
10 Mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Read
10 Mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Read
10 Mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Read
10 Mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Read
10 Mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 10 USD 455.56%
High 16 USD
Low 4 USD
Based on 2 Wall Street analysts offering 12 month price targets forFortress Biotech Inc - Dist in the last 3 months.
By TipRanks
Buy
2 ratings
2
Buy
0
Hold
0
Sell
Based on 2 analysts giving stock ratings to Fortress Biotech Inc - Dist in the past 3 months.
$